“Developing a new targeted therapy for rhabdomyosarcoma: alpha(v)beta3 and HER2 as promising targets for bispecific CAR T-cell therapy?” presented by Amanda Lulu, PhD
And
“Cancer Vaccine Plus Intratumoral IFN? or Topical TLR7 Agonist Promote Vaccine-Induced T Cell Infiltration of Melanoma Metastases” presented by Christine Tran, MD